MENS
Price
$2.02
Change
-$0.04 (-1.94%)
Updated
Aug 14 closing price
Capitalization
149.95M
Intraday BUY SELL Signals
VTGN
Price
$0.27
Change
-$0.00 (-0.00%)
Updated
Aug 14 closing price
Capitalization
11.88M
81 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

MENS vs VTGN

MENS vs VTGN Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
MENS vs. VTGN commentary
Aug 16, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MENS is a Hold and VTGN is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 16, 2026
Stock price -- (MENS: $2.02 vs. VTGN: $0.27)
Brand notoriety: MENS and VTGN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MENS: 13% vs. VTGN: 27%
Market capitalization -- MENS: $149.95M vs. VTGN: $11.88M
MENS [@Biotechnology] is valued at $149.95M. VTGN’s [@Biotechnology] market capitalization is $11.88M. The market cap for tickers in the [@Biotechnology] industry ranges from $128.19B to $0. The average market capitalization across the [@Biotechnology] industry is $2.22B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MENS’s FA Score shows that 1 FA rating(s) are green whileVTGN’s FA Score has 1 green FA rating(s).

  • MENS’s FA Score: 1 green, 4 red.
  • VTGN’s FA Score: 1 green, 4 red.
According to our system of comparison, both MENS and VTGN are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MENS’s TA Score shows that 3 TA indicator(s) are bullish while VTGN’s TA Score has 4 bullish TA indicator(s).

  • MENS’s TA Score: 3 bullish, 7 bearish.
  • VTGN’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, VTGN is a better buy in the short-term than MENS.

Price Growth

MENS (@Biotechnology) experienced а -0.49% price change this week, while VTGN (@Biotechnology) price change was -6.95% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.51%. For the same industry, the average monthly price growth was -1.43%, and the average quarterly price growth was +2992.28%.

Reported Earning Dates

VTGN is expected to report earnings on Nov 05, 2026.

Industries' Descriptions

@Biotechnology (+0.51% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MENS($150M) has a higher market cap than VTGN($11.9M). MENS YTD gains are higher at: -48.861 vs. VTGN (-59.571).
MENSVTGNMENS / VTGN
Capitalization150M11.9M1,261%
EBITDAN/A-69.2M-
Gain YTD-48.861-59.57182%
P/E RatioN/AN/A-
RevenueN/A789K-
Total CashN/A61.8M-
Total DebtN/A1.43M-
FUNDAMENTALS RATINGS
VTGN: Fundamental Ratings
VTGN
OUTLOOK RATING
1..100
41
VALUATION
overvalued / fair valued / undervalued
1..100
7
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
65
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
42

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
MENSVTGN
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
89%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
86%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
83%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
82%
Advances
ODDS (%)
Bullish Trend 11 days ago
90%
Bullish Trend 2 days ago
78%
Declines
ODDS (%)
Bearish Trend 13 days ago
90%
Bearish Trend 10 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
88%
Aroon
ODDS (%)
Bullish Trend 2 days ago
89%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
MENS
Daily Signal:
Gain/Loss:
VTGN
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RYCAX98.14N/A
N/A
Rydex Consumer Products H
RYNVX212.20N/A
N/A
Rydex Nova Inv
PCLVX25.08N/A
N/A
PACE Large Co Value Equity P
GAOZX22.39N/A
N/A
JPMorgan Global Allocation R6
JVAQX43.57N/A
N/A
JPMorgan Value Advantage R4

MENS and

Correlation & Price change

A.I.dvisor indicates that over the last year, MENS has been loosely correlated with VTGN. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if MENS jumps, then VTGN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MENS
1D Price
Change %
MENS100%
-1.94%
VTGN - MENS
58%
Loosely correlated
+0.49%
KYTX - MENS
34%
Loosely correlated
+1.11%
BNTC - MENS
28%
Poorly correlated
N/A
TRAW - MENS
25%
Poorly correlated
-4.83%
FDMT - MENS
21%
Poorly correlated
+4.64%
More